相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Isolation, characterisation, anticancer and anti-oxidant activities of 2-methoxy mucic acid from Rhizophora apiculata: an in vitro and in silico studies
A. Parthiban et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)
Analysis of circRNA profiles and clinical value in Stevens-Johnson syndrome and toxic epidermal necrolysis
Pan Lv et al.
EXPERIMENTAL DERMATOLOGY (2023)
Nrh L11R single nucleotide polymorphism, a new prediction biomarker in breast cancer, impacts endoplasmic reticulum-dependent Ca2+ traffic and response to neoadjuvant chemotherapy
Minh Quang Duong et al.
CELL DEATH & DISEASE (2023)
Targeting MCL-1 protein to treat cancer: opportunities and challenges
Shady I. Tantawy et al.
FRONTIERS IN ONCOLOGY (2023)
Expression patterns and biological function of BCL2L10 during mouse preimplantation development
Yong Liu et al.
GENE EXPRESSION PATTERNS (2022)
Last but not least: BFL-1 as an emerging target for anti-cancer therapies
Gaoyuan Wang et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2022)
BCL2L10 Is Overexpressed in Melanoma Downstream of STAT3 and Promotes Cisplatin and ABT-737 Resistance
Maria Josefina Quezada et al.
CANCERS (2021)
BCL2 and MCL1 inhibitors for hematologic malignancies
Andrew W. Roberts et al.
BLOOD (2021)
UBQLN4 is an ATM substrate that stabilizes the anti-apoptotic proteins BCL2A1 and BCL2L10 in mesothelioma
Fang Liu et al.
MOLECULAR ONCOLOGY (2021)
circTADA2A Retards the Progression of Colorectal Cancer via Regulating miR-1229/BCL2L10 Signal Axis
Li Hu et al.
CANCER MANAGEMENT AND RESEARCH (2021)
Bcl-XL: A multifunctional anti-apoptotic protein
Mingxue Li et al.
PHARMACOLOGICAL RESEARCH (2020)
BCL-w: apoptotic and non-apoptotic role in health and disease
Mariusz L. Hartman et al.
CELL DEATH & DISEASE (2020)
Severe Phenotype in a Patient With Homozygous 15q21.2 Microdeletion Involving BCL2L10, GNB5, and MYO5C Genes, Resembling Infantile Developmental Disorder With Cardiac Arrhythmias (IDDCA)
Francesca L. Sciacca et al.
FRONTIERS IN GENETICS (2020)
Nutrient Deprivation Promotes MCL-1 Degradation in an Autophagy-Independent Manner
N. V. Pervushin et al.
BIOCHEMISTRY-MOSCOW (2020)
Targeting Bcl-2 Family Proteins: What, Where, When?
V. V. Senichkin et al.
BIOCHEMISTRY-MOSCOW (2020)
Effects of annexin A7 inhibitor-ABO on the expression and distribution of long noncoding RNA-CERNA1 in vascular endothelial cells apoptosis
Wei Lu et al.
APOPTOSIS (2019)
Molecular Comprehension of Mcl-1: From Gene Structure to Cancer Therapy
Viacheslav V. Senichkin et al.
TRENDS IN CELL BIOLOGY (2019)
BCL2L10/BECN1 modulates hepatoma cells autophagy by regulating PI3K/AKT signaling pathway
Jiafa He et al.
AGING-US (2019)
The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis
Qian Ding et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
Adrien Nougarede et al.
CANCER RESEARCH (2018)
B cell lymphoma 2 (Bcl-2) residues essential for Bcl-2′s apoptosis-inducing interaction with Nur77/Nor-1 orphan steroid receptors
Karl L. Banta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Role of BCL2L10 in regulating buffalo (Bubalus bubalis) oocyte maturation
Yu-Lin Huang et al.
THERIOGENOLOGY (2018)
Genetic variations using whole-exome sequencing might predict response for neoadjuvant chemoradiotherapy in locally advanced rectal cancer
In Hee Lee et al.
MEDICAL ONCOLOGY (2018)
MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting BcI2L10
Xiaodong Wang et al.
ONCOTARGETS AND THERAPY (2018)
Subcellular Localization and Dynamics of the Bcl-2 Family of Proteins
Nikolay Popgeorgiev et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
A Balanced Translocation Disrupting BCL2L10 and PNLDC1 Segregates With Affective Psychosis
Christian G. Bouwkamp et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2017)
BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo
Yun Bai et al.
MOLECULAR CARCINOGENESIS (2017)
BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemia
Valerie Vidal et al.
ONCOTARGET (2017)
Infertility diagnosis has a significant impact on the transcriptome of developing blastocysts
Blair R. McCallie et al.
MOLECULAR HUMAN REPRODUCTION (2017)
BCLB, methylated in hepatocellular carcinoma, is a starvation stress sensor that induces apoptosis and autophagy through the AMPK-mTOR signaling cascade
Xiaolong Liu et al.
CANCER LETTERS (2017)
Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo
Emma M. Carrington et al.
CELL DEATH AND DIFFERENTIATION (2017)
Bcl2l10, a new Tpx2 binding partner, is a master regulator of Aurora kinase A in mouse oocytes
Su-Yeon Lee et al.
CELL CYCLE (2016)
BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice
Mohamed-Amine Hamouda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
IRBIT controls apoptosis by interacting with the Bcl-2 homolog, Bcl2l10, and by promoting ER-mitochondria contact
Benjamin Bonneau et al.
ELIFE (2016)
Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies
Alex R. D. Delbridge et al.
NATURE REVIEWS CANCER (2016)
Targeting BCL-2-like Proteins to Kill Cancer Cells
Suzanne Cory et al.
TRENDS IN CANCER (2016)
Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted therapy
Maja Sochalska et al.
FEBS JOURNAL (2015)
BCL2L10 is a predictive factor for resistance to Azacitidine in MDS and AML patients
Thomas Cluzeau et al.
Oncotarget (2015)
Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity
Rogier W. Rooswinkel et al.
BLOOD (2014)
Upregulation of miR-18a-5p contributes to epidermal necrolysis in severe drug eruptions
Asako Ichihara et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes
Emiliano Fabiani et al.
LEUKEMIA & LYMPHOMA (2014)
Subcellular dynamics of the maternal cell death regulator BCL2L10 in human preimplantation embryos
Jean-Francois Guerin et al.
HUMAN REPRODUCTION (2013)
Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia
E. Lainey et al.
ONCOGENE (2013)
Polyubiquitination and proteasomal turnover controls the anti-apoptotic activity of Bcl-B
B. van de Kooij et al.
ONCOGENE (2013)
The anti-apoptotic Bcl-B protein inhibits BECN1-dependent autophagic cell death
Guillaume Robert et al.
AUTOPHAGY (2012)
Diva Reduces Cell Death in Response to Oxidative Stress and Cytotoxicity
Nicole Suyun Liu et al.
PLOS ONE (2012)
Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1
Levi J. Beverly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B
R. W. Rooswinkel et al.
CELL DEATH & DISEASE (2012)
The restricted binding repertoire of Bcl-B leaves Bim as the universal BH3-only prosurvival Bcl-2 protein antagonist
G. J. P. Rautureau et al.
CELL DEATH & DISEASE (2012)
High-Throughput Screen for the Chemical Inhibitors of Antiapoptotic Bcl-2 Family Proteins by Multiplex Flow Cytometry
Ramona F. Curpan et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2011)
An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737
Sayer Al-Harbi et al.
BLOOD (2011)
BCL2L10 protein regulates apoptosis/proliferation through differential pathways in gastric cancer cells
Jing Da Xu et al.
JOURNAL OF PATHOLOGY (2011)
Involvement of BCL2 family members in the regulation of human oocyte and early embryo survival and death: gene expression and beyond
Imene Boumela et al.
REPRODUCTION (2011)
Loss of BCL2L10 protein expression as prognostic predictor for poor clinical outcome in gastric carcinoma
Jing Da Xu et al.
HISTOPATHOLOGY (2010)
Homology Modeling and Docking Studies of Human Bcl-2L10 Protein
K. Bhargavi et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2010)
Role of Bcl2-like 10 (Bcl2l10) in Regulating Mouse Oocyte Maturation
Se-Jin Yoon et al.
BIOLOGY OF REPRODUCTION (2009)
Oocytes and early embryos selectively express the survival factor BCL2L10
Yannis Guillemin et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Bcl-B expression in human epithelial and nonepithelial malignancies
Maryla Krajewska et al.
CLINICAL CANCER RESEARCH (2008)
Differential regulation of Bax and Bak by anti-apoptotic Bcl-2 family proteins Bcl-B and Mcl-1
Dayong Zhai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins
Dayong Zhai et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Altered gene expression in busulfan-resistant human myeloid leukemia
Benigno C. Valdez et al.
LEUKEMIA RESEARCH (2008)
A TR3/Nur77 peptide-based high-throughput fluorescence polarization screen for small molecule Bcl-B inhibitors
Kenneth W. Yip et al.
JOURNAL OF BIOMOLECULAR SCREENING (2008)
NM23-H2 involves in negative regulation of Diva and Bcl2L10 in apoptosis signaling
Yeongsup Kang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Functional and physical interaction between Bcl-XL and a BH3-like domain in Beclin-1
M. Chiara Maiuri et al.
EMBO JOURNAL (2007)
Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma
Frederic Luciano et al.
BLOOD (2007)
Self-eating and self-killing: crosstalk between autophagy and apoptosis
M. Chiara Maiuri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Analysis of genes upregulated by the demethylating agent 5-aza-2′-deoxycytidine in gastric cancer cell lines
Rintaro Mikata et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Functional characterization of the Bcl-2 gene family in the zebrafish
E. Kratz et al.
CELL DEATH AND DIFFERENTIATION (2006)
Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins
D. Zhai et al.
CELL DEATH AND DIFFERENTIATION (2006)
Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy
S Pattingre et al.
CELL (2005)
Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3
BZ Lin et al.
CELL (2004)
Alteration in copy numbers of genes as a mechanism for acquired drug resistance
K Yasui et al.
CANCER RESEARCH (2004)
Characterization of the anti-apoptotic mechanism of Bcl-B
DY Zhai et al.
BIOCHEMICAL JOURNAL (2003)
Marine ovarian development is not affected by inactivation of the Bcl-2 family member Diva
HR Russell et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Bcl2-L-10, a novel anti-apoptotic member of the Bcl-2 family, blocks apoptosis in the mitochondria death pathway but not in the death receptor pathway
H Zhang et al.
HUMAN MOLECULAR GENETICS (2001)
Characterization of NR13-related human cell death regulator, Boo/Diva, in normal and cancer tissues
RM Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2001)
Nrh, a human homologue of Nr-13 associates with Bcl-Xs and is an inhibitor of apoptosis
A Aouacheria et al.
ONCOGENE (2001)
Diva/Boo is a negative regulator of cell death in human glioma cells
U Naumann et al.
FEBS LETTERS (2001)
Bcl-B, a novel Bcl-2 family member that differentially binds and regulates Bax and Bak
N Ke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
